Trading Signals: SGMO Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 13, 2022)(Sangamo Therapeutics, Inc. )
| Market is closed on Sat. Jun. 18, 2022 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGMO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting SGMO price | SGMO will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA. |